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Gene delivery from biomaterial scaffolds has been employed to induce the expression of 
tissue inductive factors for applications in regenerative medicine. The delivery of viral vectors 
has been described as reflecting a balance between vector retention and release. Herein, we 
investigated the design of hydrogels in order to reain the vector at the material in order to 
enhance transgene expression. Poly(ethylene-glycol) (PEG) hydrogels were modified with poly-
L-lysine (PLL) to non-covalently bind lentivirus. For cells cultured on the hydrogels, increasing 
the PLL molecular weight from 1 kDa to 70 kDa led to increased transgene expression. The 
incubation time of the virus with the hydrogel and the PLL concentration modulated the extent of 
virus adsorption, and adsorbed virus had a 20% increase in the half-life at 37 ˚C. Alternatives to 
high molecular weight PLL were identified through page display technology, with peptide 
sequences specific for the VSV-G ectodomain, an envelope protein pseudotyped on the virus. 
These affinity peptides could easily be incorporated into the hydrogel, and expression was 
increased 20-fold relative to control peptide, and comparable to levels observed with the high 
molecular weight PLL. The modification of hydrogels with affinity proteins or peptides to bind 
lentivirus can be a powerful strategy to enhance and localized transgene expression.  
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1. Introduction 
The delivery of gene therapy vectors represents a versatile method to promote the 
sustained expression of inductive factors in numerous applications of regenerative medicine. The 
delivery of gene therapy vectors is considered versatile as the nucleotide sequence can readily be 
exchanged to express one or more factors using a single delivery system (Shen et al. 2000; 









expression, with non-viral vectors generally considere  to be safer as they generally do not 
integrate into the host chromosome, yet have significantly lower levels of transgene expression 
than viral vectors. Viral vectors have evolved mechanisms for effectively transducing target cells 
and thus provide the greatest levels of expression. In particular, lentiviral vectors have recently 
received approval in a Phase 2/3 clinical trial (Bluebird Bio 2013), and have been able to 
promote long-term transgene expression (Lentz et al. 2012). Lentiviral tropism has been greatly 
expanded by pseudotyping its envelope with the glycoprotein of the vesicular stomatitis virus 
(VSV-G) which allows the virus to infect a wide range of cell types and deliver genes to both 
dividing and non-diving cells (Bukrinsky et al. 1993; Lewis et al. 1992; Lewis and Emerman 
1993; Naldini et al. 1996). Additionally, their eas of production, relatively low immunogenic 
profile (Abordo-Adesida et al. 2005), and relatively large genetic cargo make them excellent 
candidates as gene delivery vectors. 
 Biomaterial scaffolds serve a central role in regenerative medicine by creating a space for 
tissue growth and a support for cell interactions, and they have also served as a vehicle for gene 
delivery vectors as a means to localize expression of tissue inductive factors. Localized 
expression of tissue inductive factors enables some control over the local microenvironment that 
has been effective in multiple models such as spinal cord injury and bone regeneration (Luk et al. 
2003; Thomas et al. 2014) . The delivery of viral vectors from scaffolds has been attempted 
through a variety of approaches, such as non-specific adsorption of the vector (Jen et al. 2013), 
entrapment (Raut et al. 2010),modifying the vector to bind to a material (Padmashali and 
Andreadis 2011), or modifying the material to interact with the vector. Material modifications 
have included modification of surfaces with hydroxyapatite (Boehler et al. 2013; Shin and Shea 









al. 2010). Proteins and peptides are regularly employed to functionalize biomaterials, and are 
emerging as a tool for providing binding sites for vectors on material surfaces. Poly-L-lysine 
(PLL) with a molecular weight of 70-150 kDa has been used for delivery of viral vectors 
(Phillips et al. 2008). Identifying the design requirements for peptides or proteins for promoting 
efficient gene delivery would be invaluable for developing biomaterials for use in regenerative 
medicine.  
In this report, we investigate the design parameters for peptides and proteins to enhance delivery 
of lentiviral vectors from biomaterial scaffolds. Poly(ethylene glycol) based hydrogels were 
employed as the biomaterial scaffold in these studies as they are widely used in vitro and in vivo 
for studies with cell culture, encapsulation, and transplantation and ultimately tissue formation, 
and provide a relatively low amount of non-specific binding for lentiviral vectors (Raeber et al. 
2005; Shepard et al. 2012). 4-arm PEG-acrylate hydrogels were functionalized with peptides 
containing a cysteine to provide quick and straightforward functionalization via Michael-type 
addition. The design of proteins and peptides for gene delivery initially employed PLL at a range 
of molecular weights. These studies investigated th mechanism by which PLL enhances gene 
delivery through characterizing virus binding and stability. While PLL can produce efficient 
delivery, the relatively high molecular weight and polydispersity of PLL may be a challenge for 
translation. We thus sought to identify peptides using a phage display technology, which has had 
success with identifying ligands for multiple cell types (Chamarthy et al. 2004; Hardy et al. 
2007; Mummert et al. 2000; Romanczuk et al. 1999; Samoylova and Smith 1999), proteins 
(Binetruy-Tournaire et al. 2000; Birkenmeier et al. 1997; Dore et al. 1998), and small molecules 
(Miura et al. 2004; Rodi et al. 1999; Rozinov and Nolan 1998). The peptides can provide a high 









strategies for their presentation from the hydrogel. Modifying biomaterials with peptides offers 
great potential to enhance and modulate virus localization and promote transgene expression for 
numerous regenerative medicine applications.  
 
Materials and methods 
Virus production  
Lentivirus was produced by co-transfecting HEK-293T cells with lentiviral packaging vectors 
(pMDL-GagPol, pRSV-Rev, pIVS-VSV-G), previously described by Dull et al. [9], and the gene 
of interest (pLenti-CMV-GFP and pLenti-CMV-GLuc) using jetPRIME (Polyplus Transfection, 
Illkirch, France). After 17 h, supernatant was replaced with fresh media containing 4 mM 
caffeine. After an additional 31 hours, supernatant was collected and cell debris was spun down 
and removed. Virus particles were concentrated using PEG-it (Systems Biosciences, Mountain 
View, CA) and re-suspended in PBS. Lentivirus titers were determined by qRT-PCR lentivirus 
titration kit (ABM, Inc., Richmond, Canada). Virus was further purified for SDS-PAGE gel 
analysis via a Lenti-X Maxi Purification Kit (Clonetech, Mountain View, CA) and desalted using 
a PD-10 column (GE Healthcare, Buckinghamshire, England). 
 
PLL functionalization with cysteine 
 A low molecular weight PLL (10 kDa, Alamanda Polymers, Huntsville, AL) and a high 
molecular weight PLL (30-70 kDa, Sigma Aldrich, St.Louis, MO) were functionalized with a 
cysteine using EDC/NHS chemistry to facilitate incorporation into the PEG-acrylate hydrogels. 









peptide was added to make a concentration of 1 mg/mL. After 15 minutes of incubation, the 
buffer was exchanged with centrifugal filtration (10 kDa, Amicon Ultra-0.5) to 0.1 M PBS (pH 
8) containing 30 mg/mL of oxidized cysteine. After allowing the solution to react for 2 hours, 
excess cysteine was removed via dialysis and any oxidized thiol groups were reduced with 50 
mg/mL of dithiothreitol. The PLL was quantified with a fluorescamine assay and the cysteines 
were quantified via Ellman’s test. 
 
Peptide synthesis 
Peptides were synthesized at Northwestern University’s Peptide Synthesis Core Facility 
of the Institute for BioNanotechnology in Medicine. To facilitate peptide incorporation into the 
PEG-acrylate hydrogels via Michael-type addition, a cysteine was added to the C-terminus of the 
synthesized phage display peptide. 
 
Biotinylated VSV-G 
The VSV glycoprotein ectodomain (kindly gifted by Yves Gaudin, CNRS, Unité Mixte 
de Recherche) was biotinylated using sulfo-NHS-LC-biotin (Thermo Scientific, Rockford, IL) 
according to the manufacturer’s recommended methods. Briefly, VSV-G was diluted in a 0.1 M 
NaHCO3 buffer and the biotinylation reagent was added. The reaction was incubated on ice for 
two hours then excess reagent was removed using centrifugal filtration (10 kDa, Amicon Ultra-
0.5). The degree of biotinylation on the VSV-G proteins was assayed using a fluorescence biotin 









Solution phase phage display 
 Peptides that bind to the biotinylated VSV-G protein were identified using a 12-mer 
phage display library (New England Biolabs, Ipswich, MA) using the suggested methods for 
solution phase panning. The phage library and biotinylated protein were combined in a TBS 
buffer with Tween-20 and allowed to interact. The mixture was then added to a streptavidin-
coated 96-well plate blocked with BSA and incubated for 10 minutes. Biotin (0.5 µL, 10 mM) 
was added to displace any phages bound to the streptavidin and the plates were washed 15 times 
with TBST to remove non-binding phages. Bound phages w re eluted from the immobilized 
protein by incubating in an acidic glycine elution buffer (pH 2.2) for 30 minutes followed by 
neutralization with 1 M tris buffer (pH 9.1). Phages were then amplified in E.coli and purified 
using a PEG solution (20% w/v). 
 A total of three rounds of panning were completed, with each round introducing more 
rigorous conditions to select for stronger binding candidates. Tween-20 concentration was 
increased 0.1, 0.5, and 1%, and NaCl concentration was increased 150, 300, and 750 mM. Time 
the phages spent incubating with the target protein was reduced to 60, 45, and 30 minutes. After 
the third round of panning, individual phage clones were randomly sampled and their DNA was 




Hydrogels were formed by dissolving 4-arm poly(ethylene glycol) acrylate (20 kDa) 









mg/mL. In hydrogels containing PLL, cys-functionalized PLL was added for a total 
concentration of 0.45 mg/mL, unless otherwise noted, in addition to 2.5 mM of the cell adhesion 
peptide, RGD (Ac-CGRGDS-NH3) (Celtek Peptides). TheRGD control gels contained 5 mM of 
the peptide. The PEG precursor solution was incubated  37 ˚C for 30 minutes to facilitate the 
Michael-type addition between the acrylate and thiol. T  initiate the free-radical polymerization 
of the acrylate groups, Irgacure 2959 dissolved in N-vinylpyrrolidinone (600 mg/mL) was added 
to the PEG for a final concentration of 1% (wt/vol). Gel precursor was added to non-adhesive 
silicon molds (diameter = 4.5 mm, height = 0.8 mm), cross linked with UV light for 90 seconds, 
then washed with PBS to remove unbound peptide and unreacted photoinitiator. To determine if 
virus binding to the walls of the polystyrene plate ffected the results, wells of a tissue culture 
treated 96-well plate were blocked with bovine serum albumin (5 mg/mL in 0.1 M NaHCO3 
buffer, pH = 8.6). No significant binding was observed.  
Hydrogels functionalized with peptides from the phage display panning used a 5 kDa 
PEG linker (acrylate – PEG – maleimide) (Creative PEG Works, Winston Salem, NC). The PEG 
linker was added to the PEG precursor solution at a 2.5 mM concentration then 
photopolymerized using UV light. The peptides were incubated with the virus for 3 hours and 




 Lentivirus (1 x 107 particles) was added to the gels and allowed to incubate for 3 hours at 









washed twice with 150 µL of PBS to remove unbound virus. HT1080 cells were added (104 cells 
/ well) and incubated with Dulbecco’s modified Eagle’s medium plus 10% fetal bovine serum at 
37oC, and 5% CO2. Cells expressing GFP were imaged 72 hours later, unless noted otherwise. 
The supernatant of cells expressing GLuc was gathered after 72 hours of incubation and 
measured using a Gaussia luciferase assay kit (New England BioLabs) with a luminometer 
(Turner Design, Sunnyvale, CA).  
 
Statistics  
 One-way ANOVA followed by Tukey’s posttest for multip e comparisons and two-tailed 
Student’s t-test, where appropriate, was performed using GraphPad version 5.04 for Windows 
(La Jolla, CA). Statistical significance was set at p ≤ 0.05 unless noted. Values shown represent 




PEG hydrogels were functionalized with PLL of three molecular weights and 
subsequently investigated for their ability to localize lentiviral vectors to the substrate and 
promote gene transfer. PLL was modified with cysteine for attachment to the acrylate groups on 
the PEG hydrogel. Studies were performed with varying molecular weights of PLL, which were 
incorporated at equal masses (Table 1). Hydrogels functionalized with 1 kDa, 10 kDa, or 30-70 
kDa PLL were incubated for three hours with lentivirus encoding for GFP. Fluorescence images 









GFP positive cells (Fig. 1C), while the 1 kDa PLL had almost no cells expressing the transgene 
(Fig. 1A). The high molecular weight PLL resulted in transduction of 25% of the cells, whereas 
the lowest molecular weight PLL transduced less than 0.1% of the cells (Fig. 1D). Based on its 
ability to promote the greatest extent of transduction relative to the other PLL’s, the 30-70 kDa 
was selected for further analysis. To demonstrate this system’s broad potential to transduce other 
cell types, bone marrow derived macrophages were isolated from mice and incubated with 
hydrogels functionalized with 30-70 kDa PLL (supplementary information). The extent of 
transgene expression for the virus immobilized to the hydrogel was subsequently characterized. 
The control condition for this study involved hydrogels without PLL, yet had the cell-adhesion 
peptide RGD, which is necessary for cell adhesion and provides minimal interactions with the 
virus. The assay displays effectively zero background signal in the absence of virus, indicating 
that any measured signal is produced via transgene expression (Fig. 2). Luciferase activity was 
more than 10-fold greater on the PLL-containing gels r ative to the control hydrogels, and the 
control gels were not statistically different from gels without virus.  
 
Binding dynamics, release, and stability 
We subsequently investigated the duration over which virus was incubated with 
hydrogels and the density of functionalization, as both have been previously reported to 
influence the binding of non-viral vectors and the extent of transgene expression. Hydrogels 
were functionalized with PLL and incubated with virus for times ranging from 15 to 270 
minutes. A significant increase in luciferase activity was observed for virus incubated for 90 
minutes with the hydrogels, with longer incubations f 270 minutes having no significant effect 









expression, with increasing transgene expression observed between 0.15 and 1.35 mg/mL, and 
subsequent increases to 4.05 mg/mL not significantly affecting transgene expression (Fig. 3B). 
These observed trends in incubation time and PLL concentration are consistent with those 
reported for non-viral vectors, and are likely due to the quantities of the lentivirus associated 
with the substrate.  
The release of lentivirus from PLL-functionalized PEG gels was investigated, as retention 
of the vector at the material can localize gene delivery. After virus incubation with the hydrogel 
and subsequent washing, released virus in the supernatant was collected and quantified with RT-
qPCR (Fig. 4A,B). After washing, the PLL modified hydrogel did not have detectable levels of 
virus in the supernatant (Fig. 4A). In contrast, the RGD control had a steady release of virus for 
the duration of the study (Fig. 4B). 
The stability of the immobilized virus, another factor affecting transduction, was 
subsequently investigated by incubating hydrogels with immobilized virus at 37 oC for varying 
amounts of time. Following incubation, cells were se ded onto the hydrogels and luciferase 
expression was assayed at 72 hours. Increasing times of incubation led to decreased levels of 
transgene expression for both the PLL condition and the RGD control, and this decline in activity 
was used to determine a half-life of activity. The half-life of lentivirus on the control hydrogel 
was 8.3 hours, consistent with previous reports (Higashikawa and Chang 2001; Tolmachov et al. 
2011; Zhang et al. 2004), whereas the PLL-functional zed hydrogels demonstrated a half-life of 
10. hours, a 20% increase in half-life relative to control (p≤0.05) (Fig. 5).  
 









We subsequently sought to replace the high molecular weight PLL with a peptide, which 
are routinely used to functionalize biomaterials. The low molecular weight PLL has an 
insufficient affinity for lentivirus binding, and subsequently applied phage display to identify 
peptides with a high affinity for the lentivirus. The production of lentivirus resulted in the 
presence of contaminating proteins at sufficient quantities that prohibited solution-phase phage 
display, and this technique was thus applied to the envelope protein of the lentivirus, VSV-G. 
VSV-G was biotinylated at a ratio of 0.8 mol of biotin per 1 mol of VSV-G protein. Three 
rounds of panning with the VSV-G protein were performed to enrich the phage pool for VSV-G 
binding sequences. The binding specificity of these sequences was assessed using a fourth round 
of panning with and without the VSV-G protein, with 105 pfu/µL in the presence of the VSV-G 
protein, and 101 pfu/µL in the absence of the protein. In the absence of the target protein, the titer 
of the eluted phages drops 10,000-fold, supporting the hypothesis that the phages are specifically 
interacting with VSV-G. From solutions with the target protein, 108 phage clones were 
sequenced, with 32 displaying the sequence STQHHHHSKQSR. Additionally, three other 
sequences appeared multiple times. These sequences wer  elected for further analysis (Table 2).  
The potential of these sequences to bind lentivirus and enhance gene delivery was subsequently 
investigated. Peptides were synthesized with a terminal thiol group, and initial studies 
incorporated these peptides through Michael type addition, consistent with the mechanism of 
attachment for PLL and RGD peptides. The peptide density and incubation time of the peptide 
with virus were those identified to maximize expression with PLL (Fig 3). Peptides that were 
directly incorporated into the PEG hydrogel failed to promote transgene expression. Subsequent 
studies involved attaching a 5 kDa PEG linker to the peptide, which was hypothesized to provide 









peptides promoted substantial transgene expression (Fig. 6). The four peptides identified by 
phage display provided a 6- to 20-fold increase in luciferase activity relative to RGD modified 
hydrogels (with RGD presented on a linker), and had expression levels that were comparable to 
the 30-70 kDa PLL. The use of the linker to connect the peptide to the hydrogel enhanced 
expression by the 30-70 kDa PLL relative to the absence of the linker (Fig 2). Interestingly, a 1 
kDa PLL peptide immobilized on a linker did not prom te significant gene transfer above that 
produced with RGD. Taken together, these results indicate that peptides can promote substantial 




This report investigated the design of peptides for immobilization of lentivirus to 
hydrogels and subsequently promote transgene expression. PLL is a cationic polypeptide that has 
been previously employed in non-viral gene delivery and has also been used to modify 
biomaterials to promote virus association. PLL has been proposed to associate with the lentiviral 
vector through non-specific interactions. Our studies, consistent with previous reports (Davis et 
al. 2004), demonstrated that relatively high molecular weight PLL led to greater transgene 
expression. The enhanced transgene expression likely results from the retention of virus at the 
surface, which would overcome mass transport limitations by localizing the virus to the substrate 
to which cells were adhered (Bengali et al. 2009; Luo and Saltzman 2000). Immobilization also 
served to increase the stability by approximately 20%, and the extent of immobilization 
increased through concentrations of 1.35 mg/mL and subsequently reached a plateau. Hydrogels 









decreased cell viability. Gene expression could theoretically be further manipulated by 
modifying PEG concentration, the molecular weight of PEG, and the amount of loaded virus. 
The collection of positive charges presented by the PLL provide sufficient avidity to effectively 
act to bind, yet the interaction between the virion and cell is sufficient to disrupt the PLL-
lentivirus binding. 
PEG hydrogels were functionalized with PLL at multiple molecular weights (1 kDa, 10 
kDa, and 30-70 kDa). These studies were performed for a similar extent of surface modification 
to isolate the effect of chain length. These studies monstrated a significant effect of the chain 
length, with the shortest not supporting binding, the intermediate providing low level 
transduction, and the longest providing the greatest levels of expression. The peptide RGD 
served as a control for these studies and small quantities of virus was associated with this 
condition; however, this low association may be influenced by non-specific interaction with the 
hydrogel.  
We sought to identify shorter peptides for virus immobilization, as large peptides can be 
difficult to work with, relatively expensive, and have potential for cytotoxicity. The results with 
1 kDa PLL indicated that the peptide would need greater affinity, and thus phage displayed was 
used. Phage display requires a highly pure target, which was not achievable with the existing 
lentivirus purification kits (LentiX). The crystal structure for the pre-fusion form of the VSV-G 
protein had recently been determined (Roche et al. 2007), and the purified VSV-G ectodomain 
was generously provided by the Gaudin group. Using the 12-mer library, we identified 108 
clones, and the sequences that were most commonly observed were investigated for lentivirus 
binding. The STQ sequence was obtained with the greatest frequency after sequencing the phage 









acid positions 4, 5, 6, and 7. A high abundance of ar matic amino acids could signify that the 
phages are interacting with the plastic instead of the target protein (Adey et al. 1995; Menendez 
and Scott 2005). In a fourth round of panning, the p ages showed a 10,000-fold higher binding 
affinity for wells coated with VSV-G, suggesting tha  our experiments did not identify proteins 
based on non-specific binding to the plastic.  
Peptides identified through phage display were ableto support transduction if a linker 
was employed for peptide immobilization. Initial studies with direct peptide attachment to the 
PEG hydrogel had minimal levels of transgene expression. Linkers have been used by others to 
conjugate antibodies to epidermal growth factor (EGF) , which were hypothesized to reduce 
steric hindrance and thereby improve interactions between the target (Deguchi et al. 1998). 
Peptide immobilization with a 5 kDa PEG linker led to significant transgene expression, with the 
STQ and WPG peptides providing the greatest levels of expression. Interestingly, the transgene 
expression levels obtained with the immobilized peptide were comparable to the levels obtained 
with the relatively high molecular weight PLL. A linker applied to the 30-70 kDa PLL increased 
transgene expression by approximately 80%, yet was required for the peptides. Finally, we note 
that the affinity provided by the peptides identified by phage display was necessary for 
transduction, as a 1 kDa PLL did not support gene transfer.  
 
Conclusions 
 Viral gene delivery represents a versatile tool to modify the microenvironment of 
damaged or diseased tissue and promote regeneration by converting the transduced cells into 
bioreactors to produce therapeutic proteins or downregulate undesired genes. Hydrogels are 









properties similar to native extracellular matrices, and can be readily functionalized. Hydrogels 
functionalized with proteins or peptides capable of binding lentivirus retained the virus at the 
material, enhanced the virus stability, and ultimately promoted gene transfer. High molecular 
weight proteins that non-specifically bind the lentivirus were directly attached to support binding 
and gene transfer. Alternatively, short peptides that specifically bind the lentivirus had to be 
immobilized onto biomaterials through linkers in orde  to promote binding and gene transfer, yet 
offered comparable gene expression levels. Taken together, affinity peptides or proteins can be 
attached to biomatetrials to promote the binding of ene therapy vectors and subsequent gene 
transfer, with the efficiency a function of the peptide length and binding affinity.  
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Table I. Equal masses of the different poly-L-lysines were added to provide an identical net charge for 
each condition. 
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Figure 1. Influence of PLL molecular weight on virus localiztion. PEG hydrogels containing 
2.5 mM RGD were functionalized with 0.45 mg/mL of 1 kDa (n=3) (A), 10 kDa (n=3) (B), and 
30-70 kDa (n=5) (C) PLL and incubated with GFP-encoding lentivirus. Hydrogels were washed 
to remove non-binding virus then seeded with HT1080 cells for 72 hours. (D) Significantly more 
cells were transduced with 30-70 kDa PLL than the shorter PLL’s. (*p≤0.05; ***p≤0.001) 
Figure 2. PLL enhances virus localization on PEG hydrogels. PEG hydrogels containing 2.5 mM 
RGD were functionalized with either 30-70 kDa PLL (0.45 mg/mL) or additional RGD (2.5 mM) 
(n=3). The “No virus” condition contains PLL but was incubated with PBS instead of lentivirus. 
Lentivirus encoding for GLuc was incubated with thehydrogels then washed with PBS to 
remove non-binding virus. HT1080 cells were incubated with the hydrogels for three days and 
then luciferase activity was assayed. Significant difference compared to No virus and RGD 
(****p ≤0.0001). 
Figure 3. Transgene expression can be modulated via virus-hydrogel incubation time and PLL 
concentration. (A) PEG hydrogels functionalized with 2.5 mM RGD and 0.45 mg/mL of PLL 
were incubated with virus for varying times (n=3). Fold increase in GLuc expression relative to 









Hydrogels were functionalized with varied concentrations of PLL and incubated with virus for 3 
hours (n=3). Significant difference compared to RGD control (****p ≤0.0001). 
Figure 4. Retention of lentivirus on PLL-functionalized PEG hydrogels. (A) PEG hydrogels 
containing 2.5 mM RGD were functionalized with eithr 30-70 kDa PLL or additional RGD 
(0.45 mg/mL) (n=4). Virus was incubated with the hydrogels for three hours at 37 oC then 
washed with PBS to remove non-binding virus. Unbound virus in the supernatant was collected 
and assayed via qPCR at different time points. Following the two washes, no detectable level of 
virus was found in the PLL-functionalized hydrogels. (B) The fraction of lentivirus released from 
the hydrogel was calculated by dividing the eluted virus particles by the initial virus loading. 
Significant differences between corresponding RGD and PLL conditions are denoted by an 
asterisk (**p≤0.01; ****p≤0.0001).  
Figure 5. Increased viral stability in PLL-functionalized hydrogels at 37oC. PEG hydrogels with 
2.5 mM RGD and either 30-70 kDa PLL or additional RGD (0.45 mg/mL) were incubated with 
virus at 37 oC for three hours (n=3). All hydrogels were washed an incubated with PBS. At each 
time point, the PBS was replaced with HT1080 cells and subsequent luciferase expression was 
assayed 72 hours later. (**p≤0.01; ***p≤0.001) 
Figure 6. Phage display identified peptides specific to the VSV-G protein on the lentivirus. 
Specific binding of lentivirus to phage display peptides. PEG hydrogels were functionalized with 
2.5 mM RGD and 2.5 mM of the synthesized phage display eptides conjugated with a 5 kDa 
PEG linker (n=4). HLKHTHNTHYKTCG (“HLK”), HWKPHSNLHLSRCG (“HWK”), 
STQHHHHSKQSRCG (“STQ”), and WPGHHNHSMKHKCG (“WPG”). RGD and 30-70 kDa 
PLL (0.45 mg/mL) were also functionalized to the PEG linker to serve as negative and positive 
controls, respectively. Lentivirus was incubated with the hydrogels for 3 hours followed by 
washing to remove non-binding virus. HT1080 cells were seeded on the hydrogels and luciferase 
activity was assayed 72 hours later. Fold increase in GLuc expression relative to RGD control. 





































































































































By conjugating affinity peptides to poly(ethylene-glycol) (PEG) hydrogels, lentiviral vectors 
were non-covalently bound to the hydrogel surface. Poly-L-lysine (PLL) and short, 12-amino 
acid sequences identified via phage display, were analyzed. The modification of hydrogels with 
affinity proteins or peptides to bind lentivirus can be a powerful strategy to enhance and 
localized transgene expression. 
 
. 
 
 
 
 
 
 
